Projects per year
Dr Micallef has a B.Pharm. (Hons) (Malta), MPhil in clinical bacteriology (Malta) and a PhD in clinical bacteriology (London). She is an experienced hospital pharmacist specialising in infection management and works in Addenbrookes Hospital, Cambridge University Hospitals, Cambridge, UK, as a principal pharmacist in infection management (from Jan 2013) and as an independent consultant. Dr Micallef has occupied several positions in Malta (EU) and in England, which include academic, national and hospital roles.
Her research work focuses primarily on antimicrobial stewardship initiatives and is open to collaboration.
-Educational grant from Pfizer for an Antifungal Stewardship project (January 2021)
-Commonwealth Partnership for Antimicrobial Stewardship/Fleming Fund grant (January 2019)
-NIHR RCF funding for Antibiotics in Care Homes Project (October 2013)
-Novartis® educational grant for a study entitled: An Investigation of the MICs of glycopeptides, daptomycin, tigecycline and linezolid in staphylococcal isolates from hospitalized patients at The Queen Elizabeth Hospital Kings Lynn NHS Foundation Trust (June 2010)
Dive into details
Select a country/territory to view shared publications and projects
Epidemiology, outcomes and resource utilisation in patients with carbapenem non-susceptible gram-negative bacteria in the UK: A retrospective, observational study (CARBAR UK)Goldenberg, S. D., Dodgson, A. R., Barlow, G., Parcell, B. J., Jones, L., Albur, M., Wilson, A. P. R., Enoch, D. A., Marek, A., Micallef, C., Manissero, D., Longshaw, C., Lopes, S. & Gill, K., Aug 2022, In: Advances in Therapy. 39, 8, p. 3602-3615 14 p.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile2 Downloads (Pure)
Real-world financial and clinical impact of diagnostic-driven and empirical-treatment strategies in high-risk immunocompromised patients with suspected Aspergillus infection in the United KingdomEarnshaw, S. R., McDade, C., Bryan, A., Ines, M., Micallef, C., Sung, A. & Enoch, D. A., Jun 2022, In: Microbiology Spectrum. 10, 3, e00425-22.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile4 Downloads (Pure)
Saoulidis, A. & Micallef, C., 6 Jul 2022, In: Nursing Standard. 37, 7, p. 53-59 7 p.
Research output: Contribution to journal › Article › peer-review
Reimbursement of innovative pharmaceuticals in English and Spanish hospitals—The example of isavuconazoleJeck, J., Wingen-Heimann, S. M., Thielscher, C., Kron, A., Bonn, J., Jakobs, F., Grau, S., Enoch, D. A., Micallef, C., Cornely, O. A. & Kron, F., Oct 2021, In: Mycoses. 64, 10, p. 1213-1222 10 p.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile1 Citation (Scopus)1 Downloads (Pure)
The impact of an antifungal stewardship team on voriconazole therapeutic drug monitoring in a UK tertiary hospitalJones, M., Micallef, C., Tyler, N., Wong, V. K. & Enoch, D. A., Sep 2021, In: Journal of Infection. 83, 3, p. e9-e11 3 p.
Research output: Contribution to journal › Comment/debate › peer-review1 Citation (Scopus)
- 20 Participation in conference
Christianne Micallef (Presenter (poster))9 Jul 2021 → 12 Jul 2021
Activity: Participating in or organising an event › Participation in conference